miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
about
Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialMicroRNAs and Growth Factors: An Alliance Propelling Tumor ProgressionRemodelling the extracellular matrix in development and diseaseExcess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivoIndividual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumorsIntegrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patientsOverrepresentation of transcription factor families in the genesets underlying breast cancer subtypesThe miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancerPredicting response to preoperative chemotherapy agents by identifying drug action on modeled microRNA regulation networksIdentification of miRNA-mRNA Modules in Colorectal Cancer Using Rough Hypercuboid Based Supervised ClusteringRegulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer.GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression.Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they controlIdentifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression dataENViz: a Cytoscape App for integrated statistical analysis and visualization of sample-matched data with multiple data types.Connecting rules from paired miRNA and mRNA expression data sets of HCV patients to detect both inverse and positive regulatory relationships.miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.A systematic analysis of miRNA-mRNA paired variations reveals widespread miRNA misregulation in breast cancer.In silico analysis of microRNA-510 as a potential oncomir in human breast cancerIdentification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets.Identification of the miRNA-target gene regulatory network in intracranial aneurysm based on microarray expression data.Integrated analysis of microRNA-target interactions with clinical outcomes for cancersNuclear CSPP1 expression defined subtypes of basal-like breast cancer.hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3.Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes.Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogeneAntagonism pattern detection between microRNA and target expression in Ewing's sarcoma.miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets.TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells.MicroRNA profile in very young women with breast cancerCopy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.Improving breast cancer survival analysis through competition-based multidimensional modeling.miRNome of inflammatory breast cancer.MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.T-ReCS: stable selection of dynamically formed groups of features with application to prediction of clinical outcomes.High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.MicroRNA-gene association as a prognostic biomarker in cancer exposes disease mechanismsIdentifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.
P2860
Q26782613-5E6FF7C2-D827-48B3-96C6-347953A337AEQ26796592-4604EBDA-B305-46D7-A721-C564837515A9Q26864798-BE99E6C0-3D3F-4D99-9044-F9EC6B61DD04Q27332302-B0CF0515-C7DF-453C-9EA5-B7C25C91F870Q28302352-F42327C0-FC5C-4AB3-AB98-943E29E23545Q28305345-0A7656DE-EC0A-441D-B01C-8AF866C67FCEQ28388563-6EDCBD1F-DC87-49A2-B7BE-623C88214232Q28468629-A3F49819-E148-467B-BCF8-1EBA86D88FAEQ28539028-455DA84C-61C4-43B1-B7D7-EDAA4C052DEDQ29248741-F0EE38E3-3C09-4876-AD43-559D89859DB2Q30353099-31D05BCD-86BD-4988-9EE2-6B7ADFFC26C7Q30540007-175BFD56-F464-4240-9025-183A26C498F0Q30572690-4939B1B3-E6E0-4DFB-BA98-97558D2F039DQ30577477-91D01976-3C66-464D-829F-AF5FDA1D625EQ30587051-4C3238AD-DB6C-451C-B527-C0391F7C6AD7Q30883967-F27F6BF6-A31A-4C9F-A461-6EB11B7E96C4Q30898147-E4AFD61C-B0AC-425D-9593-21C653A0235AQ31136911-874E74D6-0DE6-4C6D-B37A-08FF5ABA16B6Q33737607-E5CD9BA2-ADDD-4DC2-B7D5-94F2721C8E8AQ33739476-39E2744C-1536-46C3-B0CF-7E9148A7E2FDQ33741864-446FF66E-5146-4C96-B5D6-EB6559494DF3Q33744043-C5093E21-4082-489B-B515-CE45C19F7B56Q33912418-DA1998D9-DA16-4EC7-8494-845938C4504EQ33918128-E7E02270-FC95-4CA2-A6B5-487F28E63B27Q34031000-2CEFC5B1-72A5-4BEC-95FE-2EED4CB4A9ACQ34196315-52D9F607-E96D-4A06-80C5-203CFF6A9D1BQ34267035-6B86F6BD-61F3-4470-8FB4-8AE8768094C4Q34305782-46BF53B9-21DE-4D1C-B300-63BAF9A24E45Q34358973-25AD4488-C717-487B-9991-C19E817FB1ADQ34369490-14C07295-56DA-40AF-92B7-C2EC50D5EF8AQ34448038-C7780916-7821-4868-8967-ED91D14692A9Q34468715-C1FAD35E-0538-4E3E-9AE7-1CBA9E14965FQ34664892-405843E0-BDC3-491A-A07F-76D775C87E0DQ34720254-FEEF130D-8FBA-461C-A492-EC698E035B7EQ34896961-EDF364A3-ED2D-4E00-A59A-A3D2A8617838Q34984068-48AF34A3-70B2-4E13-8235-B4E1AED36492Q34988140-4AC42814-4F22-4FC9-9289-14CC870A8B43Q35024073-6A626F80-783F-4463-B32E-15A0325A0B82Q35052989-CCA9A646-4B9A-46AD-ACDF-A3991509EFBFQ35104159-2EAC48D1-47D3-4A22-9758-116FB459AC98
P2860
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@ast
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@de
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@en
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@nl
type
label
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@ast
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@de
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@en
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@nl
prefLabel
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@ast
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@de
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@en
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@nl
P2093
P2860
P50
P3181
P1433
P1476
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors
@en
P2093
Einar Rødland
Israel Steinfeld
Jo Anders Rønneberg
Miriam R Aure
Rami Mäkelä
Zohar Yakhini
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0016915
P407
P50
P577
2011-02-22T00:00:00Z